{"nctId":"NCT01434186","briefTitle":"A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone","startDateStruct":{"date":"2012-05"},"conditions":["Diabetes Mellitus, Type 2"],"count":32,"armGroups":[{"label":"Arm 1: Saxagliptin +Metformin XR/IR","type":"EXPERIMENTAL","interventionNames":["Drug: Metformin IR","Drug: Metformin XR","Drug: Saxagliptin"]},{"label":"Arm 2: Placebo +Metformin XR/IR","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo matching with Saxagliptin","Drug: Metformin IR","Drug: Metformin XR"]}],"interventions":[{"name":"Placebo matching with Saxagliptin","otherNames":[]},{"name":"Metformin IR","otherNames":[]},{"name":"Metformin XR","otherNames":[]},{"name":"Saxagliptin","otherNames":["BMS-477118"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male and female patients eligible if 10 years of age, up to 17 years and 30 weeks of age at the time of screening\n* Previously diagnosed as having type 2 diabetes\n* HbA1c ≥7.0% and ≤10.5%\n* Body weight ≥ 30 kg\n* Stable dose of metformin (≥ 1000mg - ≤ 2000mg) for a minimum of 2 months\n* Women must have a negative serum or urine pregnancy test\n* Women must not be breastfeeding\n\nExclusion Criteria:\n\n* Current use of anti-diabetic medications or use within the specified timeframe prior to screening (Exception: Metformin)\n* Fasting plasma glucose (FPG) \\> 255 mg/dL\n* Diabetic ketoacidosis (DKA) within 6 months of study entry\n* Abnormal renal function\n* Active liver disease\n* Anemia\n* An abnormal Thyroid Stimulating Hormone (TSH)\n* Creatinine kinase (CK) ≥ 3X ULN","healthyVolunteers":false,"sex":"ALL","minimumAge":"10 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change in HbA1c From Baseline to Week 16","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.0","spread":"0.62"},{"groupId":"OG001","value":"0.9","spread":"0.14"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":2},"commonTop":["Headache","Back pain","ABDOMINAL PAIN UPPER","OROPHARYNGEAL PAIN","Pharyngitis Streptococcal"]}}}